Article
Please stop using the adjective “elective” to describe the important health services ObGyns provide
Calling a health intervention “elective” risks miscommunicating that it is unnecessary or should have a lower priority than “...
News
Optimal sedation strategies for COVID-19 ICU patients: A work in progress
“Clinicians should consider using adjuvant agents to limit opioid exposure and improve pain scores in the critically ill,” Dr. Steven B. Greenberg...
Article
Retrospective Review on the Safety and Efficacy of Direct Oral Anticoagulants Compared With Warfarin in Patients With Cirrhosis
A retrospective chart review of adult patients with cirrhosis taking either DOACs or warfarin found no statistically significant differences in...
Article
Multidisciplinary Transitional Pain Service for the Veteran Population
A The Transitional Pain Service identified at-risk patients as soon as they were indicated for surgery, to allow time for evaluation, education,...
Article
Penicillin Allergy Delabeling Can Decrease Antibiotic Resistance, Reduce Costs, and Optimize Patient Outcomes
Many patients report an allergy to penicillin, but only a small portion have a true immune-mediated allergy, which results in a significant...
Article
Serotonin Syndrome/Serotonin Toxicity
Serotonin toxicity can result from lethal combinations of commonly prescribed medications frequently used to treat veterans.
News
Creeping fat in Crohn’s linked with microbial translocation
Microbial cultivation of Crohn’s disease samples revealed bacteria in the mesenteric tissue were associated with an exclusive consortium of five...
News
Vedolizumab shows long-term safety, efficacy
With a median cumulative exposure of approximately 3 years and some patients taking vedolizumab for more than 9 years, the study revealed no new...
News
Vedolizumab shows long-term safety, efficacy
With a median cumulative exposure of approximately 3 years and some patients taking vedolizumab for more than 9 years, the study revealed no new...
News
Bacteria may be associated with risk of MS relapse
A study of patients with pediatric-onset MS suggests that methanogenesis pathways may play a role in the risk of relapse.